Student Presenter(s): Tija Passley
Faculty Mentor: Jeorg Leheste
Department: Biomedical Sciences
School/College: College of Osteopathic Medicine, Jonesboro

The MORE Act was passed by the House of Representatives on December 4, 2020 aimed to deschedule and decriminalize use, possession, distribution, sale, and production of medical marijuana on the federal level. Additionally, other provisions include the creation of an Opportunity Trust Fund that is funded by the revenue of the Cannabis tax to cover the cost of a community reinvestment grant program for communities disproportionately affected by the War on Drugs, as well as a cannabis opportunity program for marijuana entrepreneurs and an equitable licensing program for the development of comprehensive equity programs. If the bill becomes law, it will impact a variety of public and private stakeholders, such as federal, state and local governments, law enforcement, marijuana entrepreneurs, healthcare providers, and the general public. This Health Policy Brief provides a comprehensive view of stakeholder perspectives and positions, potential benefits and pitfalls and ends with a recommendation by the authors regarding its implementation.